Cargando…

Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer

OBJECTIVE: To explore the risk factors for postoperatively pathological lymph node metastasis in patients with clinical T2N0M0 stage prostate cancer (PCa). METHODS: We retrospectively analyzed clinicopathological data of 316 patients with clinical T2 stage PCa and preoperative negative lymph nodes [...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ning, Ke, Zhi-Bin, Chen, Ye-Hui, Wu, Yu-Peng, Chen, Shao-Hao, Wei, Yong, Zheng, Qing-Shui, Huang, Jin-Bei, Li, Xiao-Dong, Xue, Xue-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456999/
https://www.ncbi.nlm.nih.gov/pubmed/32923401
http://dx.doi.org/10.3389/fonc.2020.01547
_version_ 1783575911409385472
author Xu, Ning
Ke, Zhi-Bin
Chen, Ye-Hui
Wu, Yu-Peng
Chen, Shao-Hao
Wei, Yong
Zheng, Qing-Shui
Huang, Jin-Bei
Li, Xiao-Dong
Xue, Xue-Yi
author_facet Xu, Ning
Ke, Zhi-Bin
Chen, Ye-Hui
Wu, Yu-Peng
Chen, Shao-Hao
Wei, Yong
Zheng, Qing-Shui
Huang, Jin-Bei
Li, Xiao-Dong
Xue, Xue-Yi
author_sort Xu, Ning
collection PubMed
description OBJECTIVE: To explore the risk factors for postoperatively pathological lymph node metastasis in patients with clinical T2N0M0 stage prostate cancer (PCa). METHODS: We retrospectively analyzed clinicopathological data of 316 patients with clinical T2 stage PCa and preoperative negative lymph nodes [LN(−)] indicated by imaging (cT2N0M0) between January 2014 and May 2019. Multivariate logistic regression analysis was performed to determine risk factors for postoperatively pathological pLN(+) in patients with cT2N0M0 stage PCa. Spearman correlation analysis was used to explore the relationship between tumor burden and Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) score. RESULTS: A total of 45 patients (14.2%) were confirmed by postoperative pathology to have LN metastasis. Univariate analysis indicated that total prostate-specific antigen (tPSA), PI-RADS v2 score, postoperative Gleason grade group (GGG), intraductal carcinoma of the prostate (IDC-P), clinical T2 substaging, and postoperative pathological tumor burden were risk factors for pLN(+) in all patients. Multivariate analysis showed that tPSA and postoperative GGG were risk factors for pLN(+) in all patients. Univariate analysis revealed that tPSA, PIRADS v2 score, clinical T2 substaging, IDC-P, postoperative pathological tumor burden, and postoperative GGG were risk factors for pLN(+) in patients with GGG ≥ 3. Multivariate analysis suggested that tPSA, PI-RADS v2 score, clinical T2 substaging, postoperative pathological tumor burden, and GGG were risk factors for pLN (+) in patients with GGG ≥ 3. Spearman correlation analysis showed that PI-RADS v2 score was positively correlated with clinical T2 substaging and postoperative pathological tumor burden. CONCLUSION: There was a high risk of LN metastasis in patients with cT2 PCa if they had high preoperative tPSA or high postoperative GGG. Patients with cT2 PCa and GGG ≥ 3 had a high risk of LN metastasis if they had high PI-RADS v2 score, high preoperative clinical stage or high postoperative pathological tumor burden. PI-RADS v2 score predicted tumor burden well in patients with GGG ≥ 3.
format Online
Article
Text
id pubmed-7456999
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74569992020-09-11 Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer Xu, Ning Ke, Zhi-Bin Chen, Ye-Hui Wu, Yu-Peng Chen, Shao-Hao Wei, Yong Zheng, Qing-Shui Huang, Jin-Bei Li, Xiao-Dong Xue, Xue-Yi Front Oncol Oncology OBJECTIVE: To explore the risk factors for postoperatively pathological lymph node metastasis in patients with clinical T2N0M0 stage prostate cancer (PCa). METHODS: We retrospectively analyzed clinicopathological data of 316 patients with clinical T2 stage PCa and preoperative negative lymph nodes [LN(−)] indicated by imaging (cT2N0M0) between January 2014 and May 2019. Multivariate logistic regression analysis was performed to determine risk factors for postoperatively pathological pLN(+) in patients with cT2N0M0 stage PCa. Spearman correlation analysis was used to explore the relationship between tumor burden and Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) score. RESULTS: A total of 45 patients (14.2%) were confirmed by postoperative pathology to have LN metastasis. Univariate analysis indicated that total prostate-specific antigen (tPSA), PI-RADS v2 score, postoperative Gleason grade group (GGG), intraductal carcinoma of the prostate (IDC-P), clinical T2 substaging, and postoperative pathological tumor burden were risk factors for pLN(+) in all patients. Multivariate analysis showed that tPSA and postoperative GGG were risk factors for pLN(+) in all patients. Univariate analysis revealed that tPSA, PIRADS v2 score, clinical T2 substaging, IDC-P, postoperative pathological tumor burden, and postoperative GGG were risk factors for pLN(+) in patients with GGG ≥ 3. Multivariate analysis suggested that tPSA, PI-RADS v2 score, clinical T2 substaging, postoperative pathological tumor burden, and GGG were risk factors for pLN (+) in patients with GGG ≥ 3. Spearman correlation analysis showed that PI-RADS v2 score was positively correlated with clinical T2 substaging and postoperative pathological tumor burden. CONCLUSION: There was a high risk of LN metastasis in patients with cT2 PCa if they had high preoperative tPSA or high postoperative GGG. Patients with cT2 PCa and GGG ≥ 3 had a high risk of LN metastasis if they had high PI-RADS v2 score, high preoperative clinical stage or high postoperative pathological tumor burden. PI-RADS v2 score predicted tumor burden well in patients with GGG ≥ 3. Frontiers Media S.A. 2020-08-14 /pmc/articles/PMC7456999/ /pubmed/32923401 http://dx.doi.org/10.3389/fonc.2020.01547 Text en Copyright © 2020 Xu, Ke, Chen, Wu, Chen, Wei, Zheng, Huang, Li and Xue. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Xu, Ning
Ke, Zhi-Bin
Chen, Ye-Hui
Wu, Yu-Peng
Chen, Shao-Hao
Wei, Yong
Zheng, Qing-Shui
Huang, Jin-Bei
Li, Xiao-Dong
Xue, Xue-Yi
Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer
title Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer
title_full Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer
title_fullStr Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer
title_full_unstemmed Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer
title_short Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer
title_sort risk factors for pathologically confirmed lymph nodes metastasis in patients with clinical t2n0m0 stage prostate cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456999/
https://www.ncbi.nlm.nih.gov/pubmed/32923401
http://dx.doi.org/10.3389/fonc.2020.01547
work_keys_str_mv AT xuning riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT kezhibin riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT chenyehui riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT wuyupeng riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT chenshaohao riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT weiyong riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT zhengqingshui riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT huangjinbei riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT lixiaodong riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT xuexueyi riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer